Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
    Pexels / Pixabay

    Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

      A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…

    Continue Reading Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

    Intrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease

      According to a study summarized in Gastroenterology Consultant, pregnant women with intrahepatic cholestasis of pregnancy are much more likely to also be diagnosed with nonalcoholic fatty liver disease. You can…

    Continue Reading Intrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease
    CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy
    qimono / Pixabay

    CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy

      According to a press release from the Boston Children's Hospital, a study has discovered the efficacy of CRISPR-Cas9 gene-editing technology in the treatment of facioscapulohumeral muscular dystrophy (FSHD). As…

    Continue Reading CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy
    Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment
    source: pixabay.com

    Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment

      According to a press release on Global Newswire, Novartis has received a positive opinion on Cosentyx® from the Committee for Medicinal Products for Human Use (CHMP). This positive opinion…

    Continue Reading Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment

    Post Mortem Gene Therapy Suggests Hopeful Results for Parkinson’s Disease Treatment

      Research findings can sometimes come from unexpected places. For example, according to Parkinson's News Today, the benefits and shortcomings of an investigative gene therapy were explored through the post-mortem analysis…

    Continue Reading Post Mortem Gene Therapy Suggests Hopeful Results for Parkinson’s Disease Treatment
    Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis
    Sourced from: Nephron / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

    Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis

      According to a press release from FirstWord Pharma, Gen and Alnylam Pharmaceuticals have signed an exclusive distribution deal in Turkey for RNAi therapeutic ONPATTRO. This therapy drug will treat…

    Continue Reading Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis
    Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
    source: pixabay.com

    Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out

      "A steak saved my life," writes columnist Damon Young, 41, in his article for GQ, as he shares the story of his diagnosis with Takayasu's arteritis. After over-indulging at dinner,…

    Continue Reading Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
    Questions for COVID-19: Should Cancer Patients Attend Appointments?
    Photo by National Cancer Institute on Unsplash

    Questions for COVID-19: Should Cancer Patients Attend Appointments?

      In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

    Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
    Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
    source: pixabay.com

    Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation

      In June 2019, Dicerna Pharmaceuticals submitted a clinical trial application for their DCR-A1AT therapy and expects to treat the first patient with A1AD-related liver disease near the end of…

    Continue Reading Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
    It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
    source: pixabay.com

    It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases

      As previously published in Scientific American, slightly after her first birthday, Emma Larson lost the use of her legs and started experiencing difficulty crawling. She was diagnosed with spinal muscular…

    Continue Reading It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
    New Research Discovers Childhood Neurodegenerative Disorder
    https://pixabay.com/en/nerve-cell-neuron-brain-neurons-2213009/

    New Research Discovers Childhood Neurodegenerative Disorder

    Researchers from the Murdoch Children’s Research Institute (MCRI) have recently discovered a previously unknown and uncharted neurodegenerative disorder. This rare disorder, which has not yet been named, affects children. It…

    Continue Reading New Research Discovers Childhood Neurodegenerative Disorder

    Researchers Find Immunotherapy Drug May Treat Pheochromocytoma

    Those diagnosed with paraganglioma-pheochromocytoma, squamous cell carcinoma of the skin (cSCC), adrenocortical carcinoma (ACC), and carcinoma of unknown primary (CUP) may soon have an additional option for treatment. According to…

    Continue Reading Researchers Find Immunotherapy Drug May Treat Pheochromocytoma
    Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
    source: pixabay.com

    Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases

    Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…

    Continue Reading Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases